Potentials and challenges of Levodopa particle formulation for treatment of Parkinson's disease through intranasal and pulmonary delivery
Inhalation drug delivery has gained interests in delivery of Levodopa for the treatment of Parkinson's disease. In comparison to traditional oral delivery, delivery via intranasal or pulmonary pathways allows a slower drug degradation, greater drug bioavailability, increased blood plasma concen...
Saved in:
Main Authors: | Paul, Mahasweta, Lau, Raymond |
---|---|
Other Authors: | School of Chemical and Biomedical Engineering |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160960 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Development of Levodopa-loaded inhalable dry powders for treatment of Parkinson's disease via the pulmonary system
by: Paul, Mahasweta
Published: (2022) -
Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery
by: Hadinoto, K., et al.
Published: (2014) -
Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: Effects of phospholipids
by: Hadinoto, K., et al.
Published: (2014) -
Inhalable biomimetic nanomotor for pulmonary thrombus therapy
by: Zhang, Kai, et al.
Published: (2024) -
Analysis of the influence of relative humidity on the moisture sorption of particles and the aerosolization process in a dry powder inhaler
by: Zhu, K., et al.
Published: (2014)